Brief: Candel Therapeutics Q2 Net Income USD -4.796 Million
14/08/2025 13:05
Aug 14 (Reuters) - Candel Therapeutics Q2 operating expenses USD 11.177 million. Q2 basic EPS USD -0.09 Q2 income from operations USD -11.177 million vs. IBES estimate USD -9.5 million
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Candel Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)